Orphans Elahere, Hetronifly & Hympavzi Among Eight New Products Set For EU Approval

 
• By Eliza Slawther

The European Medicines Agency has recommended the pan-EU approval of three rare disease drugs: Pfizer’s Hympavzi, Henlius Biotech’s Hetronify and ImmunoGen’s Elahere in addition to five other new medicines.

Recommended
• Source: Shutterstock

More from Europe

More from EU CHMP